A concept similar to ours was applied in ovarian cancer, with results showing that a combination of four serologic markers (leptin, prolactin, osteopontin, and insulin-like growth factor-II) had greater sensitivity and specificity for ovarian cancer than any of these markers alone [31]. This evidence concerns the gene SPP1 and ovarian carcinoma.